Company
Nectero Therapeutics
Nectero Therapeutics is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).
Also known as Nectero Medical, Nectero Medical, Inc
- Business model
- B2B
- Legal name
- Nectero Medical, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Endovascular therapy for stabilizing abdominal aortic aneurysms (AAA).
Funding snapshot
- Total raised
- $51MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $32.8M2024-04-04
Funding rounds
- Round, 2024
- $32.8M2024-04-04, SEC form D sold, 30 investors
- Round, 2021
- $18.2M2021-08-16, SEC form D sold, 31 investors
- Round, 2020
- 2020-04-30
Loading relationship preview